Location · San Francisco, CA
Clinical trials in San Francisco, CA
681 recruiting studies have a site in the San Francisco area, and 249 of them accept healthy volunteers. The area includes Oakland, Berkeley, San Mateo, Palo Alto, Stanford, Redwood City and nearby cities.
681 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Takeda
- Location
- Birmingham, AL + 42 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular…
AbbVie
- Location
- Mesa, AZ + 54 other US sites
- Eligibility basics
- Ages 50+
- Recruiting
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
W.L.Gore & Associates
- Location
- Scottsdale, AZ + 21 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation
Biogen
- Location
- Loma Linda, CA + 24 other US sites
- Eligibility basics
- Ages 18–74
- RecruitingPhase 3
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
Ipsen
- Location
- Chandler, AZ + 20 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
Sanofi
- Location
- Long Beach, CA + 9 other US sites
- Eligibility basics
- Ages 55–85
- RecruitingPhase 2
A Study of MZE782 in Adults With PKU
Maze Therapeutics
- Location
- Oakland, CA + 6 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne (AURORA)
Sagimet Biosciences Inc.
- Location
- Bryant, AR + 17 other US sites
- Eligibility basics
- Ages 12+
- Recruiting
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
SeaStar Medical
- Location
- Birmingham, AL + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell…
Incyte Corporation
- Location
- Palo Alto, CA + 29 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
Galimedix Therapeutics Inc
- Location
- Beverly Hills, CA + 1 other US site
- Eligibility basics
- Ages 55+
- RecruitingPhase 3
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
AbbVie
- Location
- Phoenix, AZ + 11 other US sites
- Eligibility basics
- Ages 2–17
- Recruiting
Diagnosing Epilepsy To EffeCT Change
Epiminder America, Inc.
- Location
- Birmingham, AL + 21 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2/Phase 3
Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia
BioMarin Pharmaceutical
- Location
- Oakland, CA + 7 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 1/Phase 2
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
Regeneron Pharmaceuticals
- Location
- Phoenix, AZ + 16 other US sites
- Eligibility basics
- Ages 2+ · Men only
- Recruiting
Prevail Global Study
Medtronic Vascular
- Location
- Birmingham, AL + 53 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
AstraZeneca
- Location
- Birmingham, AL + 151 other US sites
- Eligibility basics
- Ages 40+
- Recruiting
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
Stryker Neurovascular
- Location
- Tucson, AZ + 19 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
Laboratoires Thea
- Location
- San Francisco, CA + 3 other US sites
- Eligibility basics
- Ages 6+
- RecruitingPhase 2/Phase 3
A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis
Priovant Therapeutics, Inc.
- Location
- Birmingham, AL + 34 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD)
Restem, LLC.
- Location
- Palo Alto, CA
- Eligibility basics
- Ages 15+
- RecruitingPhase 2
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
Novartis Pharmaceuticals
- Location
- San Francisco, CA + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Regeneron Pharmaceuticals
- Location
- Dothan, AL + 41 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Novo Nordisk A/S
- Location
- Phoenix, AZ + 58 other US sites
- Eligibility basics
- Ages 18+